<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Health Technology Collaboration | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/digital-pathology-news/health-technology-collaboration/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Fri, 04 Sep 2026 11:33:31 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Health Technology Collaboration | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Hamamatsu and AIxMed Announce Collaboration to Evaluate ScanPilot Integration in Cytology Research Workflows</title>
		<link>https://tissuepathology.com/2026/09/04/hamamatsu-and-aixmed-announce-collaboration-to-evaluate-scanpilot-integration-in-cytology-research-workflows/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 04 Sep 2026 11:32:15 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[AIxMed]]></category>
		<category><![CDATA[Collaboration]]></category>
		<category><![CDATA[cytology]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[hamamatsu]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[ScanPilot]]></category>
		<category><![CDATA[Workflows]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24658</guid>

					<description><![CDATA[<p>Hamamatsu and AIxMed: The collaboration will allow interoperability between ScanPilot™ and NanoZoomer® scanners for technical image-quality assessment and autonomous rescanning in cytology. BRIDGEWATER, N.J., Sept. 3, 2026 /PRNewswire/ &#8212; Hamamatsu Corporation and AIxMed, a developer of software for digital cytology workflows, today announced a technical collaboration to evaluate the integration of AIxMed&#8217;s ScanPilot™ with selected Hamamatsu NanoZoomer® whole-slide scanner [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/04/hamamatsu-and-aixmed-announce-collaboration-to-evaluate-scanpilot-integration-in-cytology-research-workflows/">Hamamatsu and AIxMed Announce Collaboration to Evaluate ScanPilot Integration in Cytology Research Workflows</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Lumea: TreatmentGPS Launches Alpine Path Integration in Lumea’s Platform, Bringing AI-Powered Treatment Guidance Into Reports</title>
		<link>https://tissuepathology.com/2026/09/02/lumea-treatmentgps-launches-alpine-path-integration-in-lumeas-platform-bringing-ai-powered-treatment-guidance-into-reports/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 02 Sep 2026 12:39:17 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Alpine Path]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Lumea]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[reatmentGPS]]></category>
		<category><![CDATA[reports]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24653</guid>

					<description><![CDATA[<p>Lumea and TreatmentGPS today announced the Alpine Path integration into Lumea’s software. LEHI, UT, UNITED STATES, September 1, 2026 /EINPresswire.com/ &#8212; Lumea, a U.S. leader in digital pathology solutions, and TreatmentGPS, a physician-built AI platform for clinical decision support and patient education, today announced the Alpine Path integration into Lumea’s software. This integration enables guideline-based treatment guidance [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/02/lumea-treatmentgps-launches-alpine-path-integration-in-lumeas-platform-bringing-ai-powered-treatment-guidance-into-reports/">Lumea: TreatmentGPS Launches Alpine Path Integration in Lumea’s Platform, Bringing AI-Powered Treatment Guidance Into Reports</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Leica Biosystems Shares Collaboration With Mindpeak</title>
		<link>https://tissuepathology.com/2026/09/01/leica-biosystems-shares-collaboration-with-mindpeak/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 01 Sep 2026 12:36:03 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Pathology News]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24650</guid>

					<description><![CDATA[<p>From Leica Biostystems on LinkedIn: We&#8217;re excited to share the next milestone in our collaboration with Mindpeak bringing powerful AI tools closer to researchers through the Aperio AI Store. Six Mindpeak algorithms are now available on the Aperio AI Store, expanding access to AI-powered biomarker and tissue analysis applications within the Leica Biosystems digital pathology [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/01/leica-biosystems-shares-collaboration-with-mindpeak/">Leica Biosystems Shares Collaboration With Mindpeak</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Stratipath and Aiforia partner to expand access to AI-driven precision diagnostics in oncology</title>
		<link>https://tissuepathology.com/2026/08/25/stratipath-and-aiforia-partner-to-expand-access-to-ai-driven-precision-diagnostics-in-oncology/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 25 Aug 2026 12:23:25 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Aiforia partnership]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Stratipath]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24635</guid>

					<description><![CDATA[<p>August 25, 2026 &#8211; Stratipath, a leader in AI-based precision diagnostics for breast cancer, and Aiforia, a pioneer in AI-driven diagnostics in pathology, today announced a strategic partnership. This collaboration aims to provide pathologists and oncologists with broader access to validated AI-powered diagnostic and prognostic tools and sets the stage for a long-term commercial relationship [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/08/25/stratipath-and-aiforia-partner-to-expand-access-to-ai-driven-precision-diagnostics-in-oncology/">Stratipath and Aiforia partner to expand access to AI-driven precision diagnostics in oncology</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Bioptimus partners with Cancer Research Horizons to advance AI-powered precision medicine</title>
		<link>https://tissuepathology.com/2026/08/20/bioptimus-partners-with-cancer-research-horizons-to-advance-ai-powered-precision-medicine/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Thu, 20 Aug 2026 12:56:06 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Bioptimus]]></category>
		<category><![CDATA[Cancer Research Horizons]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24628</guid>

					<description><![CDATA[<p>Bioptimus to use Cancer Research Horizons’ data to train and evaluate its AI foundation model Third partnership since Bioptimus launched ground-breaking STELA initiative in March Deal adds Bioptimus&#8217; first UK patient cohort to STELA, deepening its multimodal biology model Thursday August 20th 2026, Paris, FRANCE: Bioptimus, a global AI tech company pioneering the first world [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/08/20/bioptimus-partners-with-cancer-research-horizons-to-advance-ai-powered-precision-medicine/">Bioptimus partners with Cancer Research Horizons to advance AI-powered precision medicine</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development</title>
		<link>https://tissuepathology.com/2026/08/19/imagene-ai-joins-proscia-ready-partner-alliance-to-advance-ai-powered-ihc-companion-diagnostics-development/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 19 Aug 2026 13:21:52 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[H&E tools]]></category>
		<category><![CDATA[IHC]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Imagine AI]]></category>
		<category><![CDATA[immunohistochemistry]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[precision oncology]]></category>
		<category><![CDATA[Proscia]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24624</guid>

					<description><![CDATA[<p>Imagene AI: Integration with Proscia’s Concentriq platform will facilitate pharma companies, diagnostic assay and platform providers, and CROs in operationalizing companion diagnostic programs August 18, 2026  Imagene AI, a leader in AI-powered precision oncology, today announced that it has joined the Proscia Ready partner alliance. Imagene AI is collaborating with Proscia® to integrate its advanced [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/08/19/imagene-ai-joins-proscia-ready-partner-alliance-to-advance-ai-powered-ihc-companion-diagnostics-development/">Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
